| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/21/2011 | CN101773506B Composition of cefpiramide and sodium glycinate or special solvent composition containing sodium glycinate |
| 09/21/2011 | CN101721366B Components and preparation method of beta-lactam injection |
| 09/21/2011 | CN101701068B Y-type drug delivery material with pH responsiveness and preparation method thereof |
| 09/21/2011 | CN101665576B Microgel based on cyclodextrins and preparation method thereof |
| 09/21/2011 | CN101647788B Florfenicol microcapsule and preparation method thereof |
| 09/21/2011 | CN101538236B Method for synthesizing lauroyl-prolyl amino acid methyl ester as novel transdermal enhancer and applications thereof |
| 09/21/2011 | CN101530388B Formulation of mildronate injection and preparation method |
| 09/21/2011 | CN101491680B Infectious bursal disease live-vaccine heat-proof freeze-dry protectant and preparation method thereof |
| 09/21/2011 | CN101352412B Intestinal-lysis non-steroidal antipyretic-antalgic anti-inflammatory agent and preparation thereof |
| 09/21/2011 | CN101314644B Host-guest complex type supermolecule hollow microsphere, preparation and application thereof |
| 09/21/2011 | CN101224217B Skeleton type roxithromycin sustained release pellet capsule |
| 09/21/2011 | CN101222913B Pharmaceutical composition comprising 2 , 3-dihydro-6-nitroimidazo [2 , 1-B] oxazole derivatives |
| 09/21/2011 | CN101085070B Traditional Chinese medicinal composition containing notoginseng and haw and its preparation |
| 09/21/2011 | CN101085057B Traditional Chinese medicinal composition containing red sage root, and radix paeoniae rubrathe and its preparation |
| 09/21/2011 | CN101085027B Traditional Chinese medicinal composition containing red sage root and kudzuvine root and its preparation |
| 09/21/2011 | CN101085025B Medicinal composition containing red sage root and safflower, preparation method and preparation |
| 09/21/2011 | CN101085023B Medicinal composition containing red sage root and dalbergia, preparation method and preparation |
| 09/21/2011 | CN101085022B Medicinal composition containing safflower and musk, preparation method and preparation |
| 09/21/2011 | CN101085015B Traditional Chinese medicinal composition containing red sage root, notoginseng, safflower and dalbergia oil and its preparation |
| 09/21/2011 | CN101085005B Traditional Chinese medicinal composition containing red sage root, ligusticum wallichii and dalbergia oil and its preparation |
| 09/21/2011 | CN101084948B Method for preparing saikosaponin |
| 09/21/2011 | CN101010066B Stabilised prostaglandin composition |
| 09/20/2011 | US8022191 PEG-conjugated erythropoietin |
| 09/20/2011 | US8022044 Compositions and methods for therapeutic use |
| 09/20/2011 | US8022033 Echinocandin/carbohydrate complexes |
| 09/20/2011 | US8022031 Liquid composition of factor VII polypeptides |
| 09/20/2011 | US8021708 Administering polydextrose, glycosides; for increasing production of acetate, decreasing production of butyrate, increasing population and species of beneficial bacteria and slowing rate of fermentation of prebiotics within gut |
| 09/20/2011 | US8021697 Substances having body mass redistribution properties |
| 09/20/2011 | US8021688 Solid dispersion is formed from at least one active component and a carrier characterized in that the carrier is a mixture of polyvinylpyrrolidone (PVP), a polyethylene glycol (PEG) which is semi-solid or solid at temperatures of 17 to 22 |
| 09/20/2011 | US8021686 Serum and/or intercellular degradation and clearance prevention; delivering antisense nucleic acids and/or ribozymes; high drug to lipid ratios |
| 09/20/2011 | US8021682 Palatable suspending vehicle for pharmaceutical ingredients |
| 09/20/2011 | US8021681 Obesity; antidiabetic agents ; insulin resistance; hypotensive agents; increase dopaminergic agents; controlling concentration of protein, fats, carbohydrates and calories |
| 09/20/2011 | CA2504377C Pharmaceutical preparation of recombinant factor viii lyophilized without albumin as a stabilizer |
| 09/20/2011 | CA2492874C Taste masked oral composition of telithromycin |
| 09/20/2011 | CA2484953C Microbial cellulose wound dressing for treating chronic wounds |
| 09/20/2011 | CA2476859C Water-based delivery systems |
| 09/20/2011 | CA2473209C Stimulation of the immune system with polydextrose |
| 09/20/2011 | CA2470102C Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 09/20/2011 | CA2436386C Polyacrylic film forming compositions |
| 09/20/2011 | CA2426334C Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/20/2011 | CA2418135C Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 09/20/2011 | CA2416519C Transportation of nucleic acid substances |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2399832C Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/20/2011 | CA2395814C Glp-2 formulations comprising phosphate buffer, l-histidine and mannitol or sucrose |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2367373C Medicinal compositions |
| 09/20/2011 | CA2354475C Blends of isoflavones and flavones |
| 09/20/2011 | CA2259144C Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 09/20/2011 | CA2225796C Novel formulation for peptide release |
| 09/20/2011 | CA2223573C Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/19/2011 | CA2696811A1 Glucosamin pro-drugs |
| 09/16/2011 | CA2708068A1 Hydrolyzed type i collagen composition and use for treatment of ocular tissue |
| 09/15/2011 | WO2011113000A1 Novel ester containing compositions and methods |
| 09/15/2011 | WO2011112900A2 Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 09/15/2011 | WO2011112875A2 Foamable formulation |
| 09/15/2011 | WO2011112840A2 Water-soluble phytosterol derivatives for reducing cholesterol and preparation thereof |
| 09/15/2011 | WO2011112793A2 Non-aqueous structured compositions |
| 09/15/2011 | WO2011112733A1 Carbohydrate-polyamino acid-drug conjugates |
| 09/15/2011 | WO2011112700A2 Poly(ester amide) macromers and polymers thereof |
| 09/15/2011 | WO2011112669A1 Non-aqueous high concentration reduced viscosity suspension formulations |
| 09/15/2011 | WO2011112549A2 Temperature sensitive conjugate compositions, and uses related thereto |
| 09/15/2011 | WO2011112156A1 Anti-cancer agent delivery vehicles capable of improved laoding |
| 09/15/2011 | WO2011111832A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 09/15/2011 | WO2011111818A1 Sustained release type pharmaceutical composition containing mosapride or salt thereof |
| 09/15/2011 | WO2011111809A1 Ketoprofen-containing aqueous adhesive skin patch |
| 09/15/2011 | WO2011111794A1 Fine-particle dispersion liquid manufacturing method and fine-particle dispersion liquid manufacturing apparatus |
| 09/15/2011 | WO2011111384A1 Transdermal composition containing therapeutic agent for parkinson's disease |
| 09/15/2011 | WO2011111084A1 Pharmaceutical composition based on glycyrrhizin and eg56 polymer for the preparation of anti-inflammatory products |
| 09/15/2011 | WO2011111071A1 Graft copolymer with ph dependent behaviour |
| 09/15/2011 | WO2011110939A2 Pharmaceutical compositions of substituted benzhydrylpiperazines |
| 09/15/2011 | WO2011110694A2 Micelle compositions and process for the preparation thereof |
| 09/15/2011 | WO2011110407A2 Micelle compositions and process for the preparation thereof |
| 09/15/2011 | WO2011062965A3 Targeting monomers and polymers having targeting blocks |
| 09/15/2011 | WO2011057224A3 Zwitterionic polymer bioconjugates and related methods |
| 09/15/2011 | WO2011054837A3 Bifunctional prodrugs and drugs |
| 09/15/2011 | WO2011044545A3 Methods and compositions for targeted imaging |
| 09/15/2011 | WO2011038117A3 Chemically amplified response strategies for medical sciences |
| 09/15/2011 | WO2011037550A3 Dry powder combination of tiotropium |
| 09/15/2011 | WO2011031524A3 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 09/15/2011 | WO2011029028A3 Targeted delivery using tissue-specific peptidomimetic ligands |
| 09/15/2011 | WO2010048275A3 Lyophilized recombinant vwf formulations |
| 09/15/2011 | US20110224723 Cyanoacrylate tissue adhesives |
| 09/15/2011 | US20110224313 Compositions and methods for classifying lung cancer and prognosing lung cancer survival |
| 09/15/2011 | US20110224312 Engineering porous particles of water soluble therapeutics for pressurized metered-dose inhaler formulations |
| 09/15/2011 | US20110224311 Natural Product Sweetness Enhancers |
| 09/15/2011 | US20110224310 Ceramide dispersion and method for producing same |
| 09/15/2011 | US20110224308 Organosilicone fine particles, method of production thereof and cosmetic materials, resin compositions and paint compositions containing same |
| 09/15/2011 | US20110224282 iRNA Agents Targeting VEGF |
| 09/15/2011 | US20110224246 Pharmaceutical compositions comprising ascomycin |
| 09/15/2011 | US20110224148 Carbohydrate-polyamino acid-drug conjugates |
| 09/15/2011 | US20110223645 Multivalent Carriers of Bi-Specific Antibodies |
| 09/15/2011 | US20110223257 Releasable fusogenic lipids for nucleic acids delivery systems |
| 09/15/2011 | US20110223233 Microfabricated nanopore device for sustained release of therapeutic agent |
| 09/15/2011 | US20110223226 Shelf stable capsules |
| 09/15/2011 | US20110223225 Solid oil powders |
| 09/15/2011 | US20110223217 Block copolymers and uses thereof |
| 09/15/2011 | US20110223206 Micelle compositions and process for the preparation thereof |
| 09/15/2011 | US20110223167 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |